US EditionBiohaven Ltd. (NYSE:BHVN) Shares Acquired by Ameriprise Financial Inc.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Biohaven Ltd. (NYSE:BHVN) Shares Acquired by Ameriprise Financial Inc.
Ameriprise Financial Inc. lifted its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 40.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 508,682 shares of the company’s stock after acquiring an additional 145,331 shares during the quarter. Ameriprise Financial Inc.’s holdings in Biohaven were worth $18,994,000 as of its most recent […]
FDA Delays Biohaven's Rare Disease Drug Approval, Impacting Share Prices
The FDA has postponed its decision on Biohaven’s drug troriluzole, intended to treat rare nerve-destroying diseases, by a few months and will convene an advisory committee to further assess the application. This move marks a shift from previous discussions, where no advisory meeting was planned, indicating potential concerns or unresolved questions about the drug’s data. Troriluzole, a key candidate in Biohaven’s pipeline, could mark a new chapt…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
